| SLE mean ± SD | Control mean ± SD | p value |
---|---|---|---|
Age, years | 46.9 ± 8.9 | 52.8 ± 11.0 | 0.09 |
Race, % who were Caucasian | 75 | 80 | 0.98 |
Body mass index, kg/m2 | 27.7 ± 7.7 | 28.3 ± 4.9 | 0.79 |
Waist-hip ratio | 0.85 ± 0.07 | 0.86 ± 0.08 | 0.69 |
Systolic blood pressure, mm Hg | 117.4 ± 13.2 | 116.8 ± 14.4 | 0.88 |
Diastolic blood pressure, mm Hg | 72.3 ± 9.0 | 71.8 ± 11.5 | 0.79 |
Current smoking, % | 20 | 26.7 | 0.65 |
Diabetes, % | 5 | 6 | 0.93 |
Family history of cardiovascular disease, % | 10 | 7 | 0.74 |
Menopausal, % | 45 | 53 | 0.64 |
Cardiovascular events | 0 | 0 | n/a |
Total cholesterol, mg/dL | 188.9 ± 51.9 | 218.9 ± 41.4 | 0.12 |
LDLc, mg/dL | 101.5 ± 41.5 | 139.0 ± 8.7 | 0.04 |
Triglycerides, mg/dL | 125.6 ± 99.9 | 101.0 ± 48.9 | 0.44 |
Glucose, mg/dL | 98.4 ± 10.7 | 103.7 ± 13.9 | 0.27 |
Glomerular filtration rate, mL/min | 80.7 ± 17.8 | 77.9 ± 18.8 | 0.65 |
C-reactive protein, mg/L | 3.5 ± 3.6 | 3.8 ± 6.3 | 0.91 |
C3, mg/dL | 101.5 ± 21.5 |  |  |
C4, mg/dL | 20.3 ± 8.4 |  |  |
dsDNA (crithidia) level | 66.3 | Â | Â |
Presence of carotid plaque | 45 | 53 | 0.65 |
Higher CAC score (>10), % | 35 | 33 | 0.92 |
Higher AC score (>100), % | 50 | 47 | 0.85 |
Intima-media thickness (mean ± SD) | 0.65 ± 0.14 | 0.71 ± 0.21 | 0.27 |
Atherosclerosis phenotype, % | 50 | 62.5 | 0.47 |
SLEDAI-2 K | 4.2 ± 4.3 |  |  |
SLICC/ACR-DI | 2.2 ± 1.8 |  |  |
Disease duration, years | 16.3 ± 8.2 |  |  |
Total ACR SLE classification criteria (median) | 5 | Â | Â |
Corticosteroids | 30 | 0 | 0.01 |
Hydroxychloroquine | 65 | 0 | 0.00001 |
Immunosuppressants | 40 | 0 | 0.002 |
Statins | 35 | 0 | 0.03 |
Antihypertensives | 45 | 25 | 0.09 |